서울대학교 중앙도서관

S-Space 소개

My S-Space

로그인이 필요합니다.

Login

S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 6 of 6

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2012-11	Phase I and pharmacokinetic study of IHL-305 (PEGylated liposomal irinotecan) in patients with advanced solid tumors Infante, Jeffrey R.; Keedy, Vicki L.; Jones, Suzanne F.; Zamboni, William C.; Chan, Emily; Bendell, Johanna C.; Lee, Wooin; Wu, Huali; Ikeda, Satoshi; Kodaira, Hiroshi; Rothenberg, Mace L.; Burris, Howard A., III Cancer Chemotherapy and Pharmacology, Vol.70 No.5, pp.699-705	DOI
2013-12	Population pharmacokinetics of PEGylated liposomal CPT-11 (IHL-305) in patients with advanced solid tumors Wu, Huali; Infante, Jeffrey R.; Keedy, Vicki L.; Jones, Suzanne F.; Chan, Emily; Bendell, Johanna C.; Lee, Wooin; Zamboni, Beth A.; Ikeda, Satoshi; Kodaira, Hiroshi; Rothenberg, Mace L.; Burris, Howard A., III; Zamboni, William C. European Journal of Clinical Pharmacology, Vol.69 No.12, pp.2073-2081	DOI
2015-02	Factors affecting the pharmacokinetics and pharmacodynamics of PEGylated liposomal irinotecan (IHL-305) in patients with advanced solid tumors Wu, Huali; Infante, Jeffrey R.; Keedy, Vicki L.; Jones, Suzanne F.; Chan, Emily; Bendell, Johanna C.; Lee, Wooin; Kirschbrown, Whitney P.; Zamboni, Beth A.; Ikeda, Satoshi; Kodaira, Hiroshi; Rothenberg, Mace L.; Burris, Howard A., III; Zamboni, William C. International Journal of Nanomedicine, Vol.10 No.1, pp.1201-1209	DOI
2020-01	Population pharmacokinetics of vactosertib, a new TGF-β receptor type Ι inhibitor, in patients with advanced solid tumors Jung, Su Young; Yug, Ji Seob; Clarke, Jeffery M.; Bauer, Todd M.; Keedy, Vicki L.; Hwang, Sunjin; Kim, Seong-Jin; Chung, Eun Kyoung; Lee, Jangik I. Cancer Chemotherapy and Pharmacology, Vol.85 No.1, pp.173-183	DOI
2020-06	Pharmacokinetic characteristics of vactosertib, a new activin receptor-like kinase 5 inhibitor, in patients with advanced solid tumors in a first-in-human phase 1 study Jung, Su Young; Hwang, Sunjin; Clarke, Jeffery M.; Bauer, Todd M.; Keedy, Vicki L.; Lee, Hukeun; Park, Neunggyu; Kim, Seong-Jin; Lee, Jangik I. Investigational New Drugs, Vol.38 No.3, pp.812-820	DOI
2022-03	Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of nuclear protein of the testis carcinoma and other cancers: Results of a Phase I/II open-label, dose escalation study Cousin, Sophie; Blay, Jean-Yves; Garcia, Irene Brana; de Bono, Johann S.; Le Tourneau, Christophe; Moreno, Victor; Trigo, Jose; Hann, Christine L.; Azad, Arun A.; Im, Seock-Ah; Cassier, Philippe A.; French, Christopher A.; Italiano, Antoine; Keedy, Vicki L.; Plummer, Ruth; Sablin, Marie-Paule; Hemming, Matthew L.; Ferron-Brady, Geraldine; Wyce, Anastasia; Khaled, Ahmed; Datta, Antara; Foley, Shawn W.; McCabe, Michael T.; Wu, Yuehui; Horner, Thierry; Kremer, Brandon E.; Dhar, Arindam; O'Dwyer, Peter J.; Shapiro, Geoffrey I.; Piha-Paul, Sarina A. International Journal of Cancer, Vol.150 No.6, pp.993-1006	DOI

1